Patent · US Active

Pharmaceutical formulations: salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxy-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same

US9345692B2 · kind B2 · utility

2Cited by

17References

5Claims

0Family size

Assignee

OPKO Health, Inc. · US

Inventors

Zhihui Qiu · Bound Brook, US
Larisa Reyderman · Watchung, US

Key dates

Filing date	Mar 19, 2013
Grant date	May 24, 2016
Priority date	—
Expiry date	May 20, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical formulations containing salts of (5S,8S)-8-[{(1R)-1-(3,5-Bis-(trifluoromethyl)phenyl]-ethoxy}-methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one, represented by Formula I, are disclosed. Disclosed also are methods of treatment utilizing such dosage forms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.